Basic research for oral cancer therapy by anti-cancer drugs and apoptosis-inducing factor
抗癌药物和凋亡诱导因子治疗口腔癌的基础研究
基本信息
- 批准号:09557171
- 负责人:
- 金额:$ 7.04万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We investigated the effects of anti-cancer drugs (CDDP, 5-Fu) , IFN-y or NO donors(SNP, SNAP, NOC) on induction of apoptosis mainly in NA cells which had been established from a squamous cell carcinoma of the tongue. Further the effects of these agents on the expression of c-myc and c-myb, adhesion molecules including ICAM-1, Fas/Fas ligand, and soluble Fas were also studied in NA cells. The results obtained were as follows :1. When NA cells were treated with NO donors, apoptosis of NA cells was induced together with the inhibition of the expression of c-myc and c-myb mRNA.2. CDDP and 5-Eu induced apoptosis of NA cells and it was suggested that FLICE (caspase 8) might be concerned in the induction of apoptosis of NA cells. However, synergistic -effect was not observed when NA cells were treated both with these anti-cancer drugs.3. ICAM-1 expression on NA cells was enhanced by the treatment of CDDP or 5- Eu, and simultaneous treatment with CDDP and 5-Eu exhibited synergistic effect on the induction of ICAM-1.4. Apoptosis was induced when NA cells were treated with IEN-gamma or anti-Fas antibody (CH11). Then, membrane binding Fas was not altered, whereas soluble Eas in the medium was decreased.5. The expression of Fas and Fas ligand on HL-60 cells, a leukemia cell line, was enhanced by the treatment with IEN-gamma or TNF-alpha, while the expression of bcl-2 protein and its mRNA was reduced by the treatment.These results indicate that apoptosis is induced both by anti-cancer drugs or NO donors and that the induction of apoptosis is enhanced by IFN-gamma or TNF-alpha.
我们研究了抗癌药物(CDDP、5-Fu)、IFN-y 或 NO 供体(SNP、SNAP、NOC)对主要在从舌鳞状细胞癌建立的 NA 细胞中诱导细胞凋亡的影响。此外,还在 NA 细胞中研究了这些药物对 c-myc 和 c-myb、粘附分子(包括 ICAM-1、Fas/Fas 配体和可溶性 Fas)表达的影响。得到的结果如下: 1. NO供体处理NA细胞后,可诱导NA细胞凋亡,同时抑制c-myc和c-myb mRNA的表达。2. CDDP和5-Eu诱导NA细胞凋亡,提示FLICE(caspase 8)可能参与诱导NA细胞凋亡。然而,当NA细胞同时用这些抗癌药物处理时,没有观察到协同效应。3. CDDP或5-Eu处理可增强NA细胞上ICAM-1的表达,CDDP和5-Eu同时处理对ICAM-1.4的诱导表现出协同作用。当 NA 细胞用 IEN-gamma 或抗 Fas 抗体 (CH11) 处理时,会诱导细胞凋亡。然后,膜结合Fas没有改变,而培养基中可溶性Eas减少。5. IEN-γ或TNF-α处理后,白血病细胞系HL-60细胞上Fas和Fas配体的表达增强,而bcl-2蛋白及其mRNA的表达降低。结果表明,抗癌药物或NO供体均可诱导细胞凋亡,并且IFN-γ或TNF-α可增强细胞凋亡的诱导。
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
滝沢邦生 他: "cisplatin, s-flaorourocil併用による癌細胞の細胞接着因子発現誘導とT細胞の抗腫瘍効果誘導" Proceding of the Japanese Cancer Association (56th Annual Meeting). 88(Sup). 375-375 (1997)
Kunio Takizawa 等:“联合使用顺铂和 s-flaorourocil 诱导癌细胞中的细胞粘附因子表达和诱导 T 细胞的抗肿瘤作用”日本癌症协会会议记录(第 56 届年会)88(Sup)。 375-375(1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohashi M.et al: "Upregulation of Fos/Fasligand expression by IFN-γ_<61> TNF-α on HL-60 cells" Molecular Biology of the Cell.8. 249-249 (1997)
Ohashi M.等人:“HL-60细胞上IFN-γ_61TNF-α对Fos/Fas配体表达的上调”《细胞分子生物学》249-249(1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takizawa K.et al: "Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorounacil in a cancer cell line via a NF-κB independent pathuay" Brit Journal of Cancer. (in press). (1999)
Takizawa K. 等人:“顺铂和 5-氟尿嘧啶通过 NF-κB 独立途径协同诱导癌细胞系中的 ICAM-1 表达”(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwase M.et al: "Clinical trial of recombinant Granulocyte colony-stimulating factor for chcmotherapy-induced neutropenia inpatient with oral cancer." J Oral Maxillofac Suig. 55. 836-840 (1997)
Iwase M.等人:“重组粒细胞集落刺激因子治疗口腔癌住院患者化疗引起的中性粒细胞减少症的临床试验。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takizawa K,et al: "Induction of socuble Fosrelease from cancercells by interferox-r" Molecular Biology of the Call.8. 248-248 (1997)
Takizawa K,et al:“Induction of socuble Fosrelease from cancercells by interferox-r”分子生物学的 Call.8。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGUMO Masao其他文献
NAGUMO Masao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGUMO Masao', 18)}}的其他基金
Prediction of malignant transformation of oral precancerous lesions by analyzing gene expression profiles and gene polymorphism.
通过分析基因表达谱和基因多态性预测口腔癌前病变恶变。
- 批准号:
15209070 - 财政年份:2003
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
The participation of p53 independent pathway in the process of oral carcinogenesis
p53独立途径参与口腔癌发生过程
- 批准号:
13470439 - 财政年份:2001
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The effects of CDK inhibitors and PI3 kinase related kinase on the carcinogenesis from precancerous lesions
CDK抑制剂和PI3激酶相关激酶对癌前病变癌变的影响
- 批准号:
11470443 - 财政年份:1999
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of detection method of metastasis from squamous cell carcinoma of head and neck using peripheral blood
外周血检测头颈部鳞状细胞癌转移方法的建立
- 批准号:
11557163 - 财政年份:1999
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Cell cycle and apoptosis in the process of carcinogenesis in oral precancerous lesions
口腔癌前病变癌变过程中的细胞周期与凋亡
- 批准号:
08457554 - 财政年份:1996
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Apoptosis in the process of carcinogenesis of oral precancerous lesions
口腔癌前病变癌变过程中的细胞凋亡
- 批准号:
06454572 - 财政年份:1994
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Changes of cytokines and their gene expression in the process of carcinogenesis of oral precancerous lesions
口腔癌前病变癌变过程中细胞因子及其基因表达的变化
- 批准号:
04454511 - 财政年份:1992
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Studies of IFN, IL-1, and Tnf on Induction of Differentiation and Activation of Neutrophils.
IFN、IL-1 和 Tnf 对中性粒细胞分化和激活诱导的研究。
- 批准号:
63480448 - 财政年份:1988
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
可打印的个性化黑磷/5-FU药物递送系统用于皮肤癌的光热-化疗协同治疗研究
- 批准号:52372265
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
5-FU通过促进3-磷酸甘油酸脱氢酶(PHGDH)核转位维持肿瘤干细胞干性影响结直肠癌化疗耐药的机制研究
- 批准号:82373134
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
m6A甲基化上调LDHA调控糖酵解促进结直肠癌5-FU耐药的作用及机制研究
- 批准号:82272658
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
S1PR2拮抗剂设计、合成及其逆转结肠癌对5-FU耐药的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
整合多模态数据构建结直肠癌5-FU耐药预测模型的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
5-FU系抗がん剤による味覚障害に対する消化管味覚受容体を介した新たな治療戦略
胃肠道味觉受体介导治疗5-FU抗癌药物味觉障碍的新策略
- 批准号:
23K06721 - 财政年份:2023
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of KIFC1 in 5-FU resistance of colorectal cancer
KIFC1在结直肠癌5-FU耐药中的作用
- 批准号:
23K15498 - 财政年份:2023
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
トリステアリンミセルを用いた「食べるDDS」の開発研究
使用三硬脂酸胶束的“食用DDS”的研发
- 批准号:
22K05526 - 财政年份:2022
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
細胞周期DNA修復からみた5-FU抵抗性大腸癌の治療強化法とターゲット蛋白の同定
5-FU耐药结直肠癌的治疗强化方法及从细胞周期DNA修复角度识别靶蛋白
- 批准号:
22K16539 - 财政年份:2022
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment a new 5-FU therapy in pancreatic cancer through the combination of tumor-specific DPD expression inhibitory compounds
通过联合肿瘤特异性DPD表达抑制化合物建立胰腺癌新5-FU疗法
- 批准号:
20K16225 - 财政年份:2020
- 资助金额:
$ 7.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists